Evaluation of the Pharmacokinetics and Pharmacodynamics of Liposomal Amikacin for Inhalation in Cystic Fibrosis Patients with Chronic Pseudomonal Infections Using Data from Two Phase 2 Clinical Studies

The pharmacokinetic-pharmacodynamic (PK-PD) relationships between serum exposure measures of liposomal amikacin for inhalation (LAI) and the change in pulmonary function test (PFT) measures and number of CFU from baseline were evaluated in cystic fibrosis (CF) patients chronically infected with Pseu...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Okusanya, Olanrewaju O., Bhavnani, Sujata M., Hammel, Jeffrey P., Forrest, Alan, Bulik, Catharine C., Ambrose, Paul G., Gupta, Renu
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology 2014
Ämnen:
Pharmacology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4135881/
https://ncbi.nlm.nih.gov/pubmed/24687506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02421-13
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk